Global Atorvastatin Calcium Market Insights, Forecast to 2025


    Table of Contents

      1 Study Coverage

      • 1.1 Atorvastatin Calcium Product
      • 1.2 Market Segments
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Atorvastatin Calcium Market Size Growth Rate by Product
        • 1.4.2 Chemical Synthesis
        • 1.4.3 Biocatalysis
        • 1.4.4 Others
      • 1.5 Market by End User
        • 1.5.1 Global Atorvastatin Calcium Market Size Growth Rate by End User
        • 1.5.2 Tablet (Including Dispersible Tablet and General Tablet)
        • 1.5.3 Capsule
        • 1.5.4 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Atorvastatin Calcium Market Size
        • 2.1.1 Global Atorvastatin Calcium Revenue 2014-2025
        • 2.1.2 Global Atorvastatin Calcium Sales 2014-2025
      • 2.2 Atorvastatin Calcium Growth Rate by Regions
        • 2.2.1 Global Atorvastatin Calcium Sales by Regions
        • 2.2.2 Global Atorvastatin Calcium Revenue by Regions

      3 Breakdown Data by Manufacturers

      • 3.1 Atorvastatin Calcium Sales by Manufacturers
        • 3.1.1 Atorvastatin Calcium Sales by Manufacturers
        • 3.1.2 Atorvastatin Calcium Sales Market Share by Manufacturers
        • 3.1.3 Global Atorvastatin Calcium Market Concentration Ratio (CR5 and HHI)
      • 3.2 Atorvastatin Calcium Revenue by Manufacturers
        • 3.2.1 Atorvastatin Calcium Revenue by Manufacturers (2014-2019)
        • 3.2.2 Atorvastatin Calcium Revenue Share by Manufacturers (2014-2019)
      • 3.3 Atorvastatin Calcium Price by Manufacturers
      • 3.4 Atorvastatin Calcium Manufacturing Base Distribution, Product Types
        • 3.4.1 Atorvastatin Calcium Manufacturers Manufacturing Base Distribution, Headquarters
        • 3.4.2 Manufacturers Atorvastatin Calcium Product Type
        • 3.4.3 Date of International Manufacturers Enter into Atorvastatin Calcium Market
      • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

      4 Breakdown Data by Product

      • 4.1 Global Atorvastatin Calcium Sales by Product
      • 4.2 Global Atorvastatin Calcium Revenue by Product
      • 4.3 Atorvastatin Calcium Price by Product

      5 Breakdown Data by End User

      • 5.1 Overview
      • 5.2 Global Atorvastatin Calcium Breakdown Data by End User

      6 North America

      • 6.1 North America Atorvastatin Calcium by Countries
        • 6.1.1 North America Atorvastatin Calcium Sales by Countries
        • 6.1.2 North America Atorvastatin Calcium Revenue by Countries
        • 6.1.3 United States
        • 6.1.4 Canada
        • 6.1.5 Mexico
      • 6.2 North America Atorvastatin Calcium by Product
      • 6.3 North America Atorvastatin Calcium by End User

      7 Europe

      • 7.1 Europe Atorvastatin Calcium by Countries
        • 7.1.1 Europe Atorvastatin Calcium Sales by Countries
        • 7.1.2 Europe Atorvastatin Calcium Revenue by Countries
        • 7.1.3 Germany
        • 7.1.4 France
        • 7.1.5 UK
        • 7.1.6 Italy
        • 7.1.7 Russia
      • 7.2 Europe Atorvastatin Calcium by Product
      • 7.3 Europe Atorvastatin Calcium by End User

      8 Asia Pacific

      • 8.1 Asia Pacific Atorvastatin Calcium by Countries
        • 8.1.1 Asia Pacific Atorvastatin Calcium Sales by Countries
        • 8.1.2 Asia Pacific Atorvastatin Calcium Revenue by Countries
        • 8.1.3 China
        • 8.1.4 Japan
        • 8.1.5 Korea
        • 8.1.6 India
        • 8.1.7 Australia
        • 8.1.8 Indonesia
        • 8.1.9 Malaysia
        • 8.1.10 Philippines
        • 8.1.11 Thailand
        • 8.1.12 Vietnam
        • 8.1.13 Singapore
      • 8.2 Asia Pacific Atorvastatin Calcium by Product
      • 8.3 Asia Pacific Atorvastatin Calcium by End User

      9 Central & South America

      • 9.1 Central & South America Atorvastatin Calcium by Countries
        • 9.1.1 Central & South America Atorvastatin Calcium Sales by Countries
        • 9.1.2 Central & South America Atorvastatin Calcium Revenue by Countries
        • 9.1.3 Brazil
      • 9.2 Central & South America Atorvastatin Calcium by Product
      • 9.3 Central & South America Atorvastatin Calcium by End User

      10 Middle East and Africa

      • 10.1 Middle East and Africa Atorvastatin Calcium by Countries
        • 10.1.1 Middle East and Africa Atorvastatin Calcium Sales by Countries
        • 10.1.2 Middle East and Africa Atorvastatin Calcium Revenue by Countries
        • 10.1.3 GCC Countries
        • 10.1.4 Turkey
        • 10.1.5 Egypt
        • 10.1.6 South Africa
      • 10.2 Middle East and Africa Atorvastatin Calcium by Product
      • 10.3 Middle East and Africa Atorvastatin Calcium by End User

      11 Company Profiles

      • 11.1 Pfizer
        • 11.1.1 Pfizer Company Details
        • 11.1.2 Company Business Overview
        • 11.1.3 Pfizer Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.1.4 Pfizer Atorvastatin Calcium Products Offered
        • 11.1.5 Pfizer Recent Development
      • 11.2 DSM Sinochem Pharmaceuticals
        • 11.2.1 DSM Sinochem Pharmaceuticals Company Details
        • 11.2.2 Company Business Overview
        • 11.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.2.4 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Products Offered
        • 11.2.5 DSM Sinochem Pharmaceuticals Recent Development
      • 11.3 Cadila Pharmaceuticals
        • 11.3.1 Cadila Pharmaceuticals Company Details
        • 11.3.2 Company Business Overview
        • 11.3.3 Cadila Pharmaceuticals Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.3.4 Cadila Pharmaceuticals Atorvastatin Calcium Products Offered
        • 11.3.5 Cadila Pharmaceuticals Recent Development
      • 11.4 Sun Pharmaceutical Industries
        • 11.4.1 Sun Pharmaceutical Industries Company Details
        • 11.4.2 Company Business Overview
        • 11.4.3 Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.4.4 Sun Pharmaceutical Industries Atorvastatin Calcium Products Offered
        • 11.4.5 Sun Pharmaceutical Industries Recent Development
      • 11.5 Dr. Reddy’s
        • 11.5.1 Dr. Reddy’s Company Details
        • 11.5.2 Company Business Overview
        • 11.5.3 Dr. Reddy’s Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.5.4 Dr. Reddy’s Atorvastatin Calcium Products Offered
        • 11.5.5 Dr. Reddy’s Recent Development
      • 11.6 Morepen
        • 11.6.1 Morepen Company Details
        • 11.6.2 Company Business Overview
        • 11.6.3 Morepen Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.6.4 Morepen Atorvastatin Calcium Products Offered
        • 11.6.5 Morepen Recent Development
      • 11.7 Teva Pharmaceutical Industries
        • 11.7.1 Teva Pharmaceutical Industries Company Details
        • 11.7.2 Company Business Overview
        • 11.7.3 Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.7.4 Teva Pharmaceutical Industries Atorvastatin Calcium Products Offered
        • 11.7.5 Teva Pharmaceutical Industries Recent Development
      • 11.8 Apotex Pharmachem
        • 11.8.1 Apotex Pharmachem Company Details
        • 11.8.2 Company Business Overview
        • 11.8.3 Apotex Pharmachem Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.8.4 Apotex Pharmachem Atorvastatin Calcium Products Offered
        • 11.8.5 Apotex Pharmachem Recent Development
      • 11.9 Sandoz Inc
        • 11.9.1 Sandoz Inc Company Details
        • 11.9.2 Company Business Overview
        • 11.9.3 Sandoz Inc Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.9.4 Sandoz Inc Atorvastatin Calcium Products Offered
        • 11.9.5 Sandoz Inc Recent Development
      • 11.10 Mylan Pharmaceuticals Inc.
        • 11.10.1 Mylan Pharmaceuticals Inc. Company Details
        • 11.10.2 Company Business Overview
        • 11.10.3 Mylan Pharmaceuticals Inc. Atorvastatin Calcium Sales, Revenue and Gross Margin (2014-2019)
        • 11.10.4 Mylan Pharmaceuticals Inc. Atorvastatin Calcium Products Offered
        • 11.10.5 Mylan Pharmaceuticals Inc. Recent Development
      • 11.11 Kremers Urban Pharmaceuticals Inc.
      • 11.12 ScieGen Pharmaceuticals, Inc.
      • 11.13 Zheijang Neo-Dankon Pharmaceutical
      • 11.14 Ningbo Menovo Pharmaceuticals Group
      • 11.15 Jialin Pharmaceutical
      • 11.16 Topfond
      • 11.17 Zhejiang Hisun Pharmacutical
      • 11.18 Zhejiang Hongyuan Pharmaceutical
      • 11.19 Hubei Yitai Pharmaceutical
      • 11.20 Jiangsu Hengrui Medicine

      12 Future Forecast

      • 12.1 Atorvastatin Calcium Market Forecast by Regions
        • 12.1.1 Global Atorvastatin Calcium Sales Forecast by Regions 2019-2025
        • 12.1.2 Global Atorvastatin Calcium Revenue Forecast by Regions 2019-2025
      • 12.2 Atorvastatin Calcium Market Forecast by Product
        • 12.2.1 Global Atorvastatin Calcium Sales Forecast by Product 2019-2025
        • 12.2.2 Global Atorvastatin Calcium Revenue Forecast by Product 2019-2025
      • 12.3 Atorvastatin Calcium Market Forecast by End User
      • 12.4 North America Atorvastatin Calcium Forecast
      • 12.5 Europe Atorvastatin Calcium Forecast
      • 12.6 Asia Pacific Atorvastatin Calcium Forecast
      • 12.7 Central & South America Atorvastatin Calcium Forecast
      • 12.8 Middle East and Africa Atorvastatin Calcium Forecast

      13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

      • 13.1 Market Opportunities and Drivers
      • 13.2 Market Challenges
      • 13.3 Market Risks/Restraints
      • 13.4 Macroscopic Indicators

      14 Value Chain and Sales Channels Analysis

      • 14.1 Value Chain Analysis
      • 14.2 Atorvastatin Calcium Customers
      • 14.3 Sales Channels Analysis
        • 14.3.1 Sales Channels
        • 14.3.2 Distributors

      15 Research Findings and Conclusion

        16 Appendix

        • 16.1 Research Methodology
          • 16.1.1 Methodology/Research Approach
          • 16.1.2 Data Source
        • 16.2 Author Details

        Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
        Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
        India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.
        The global Atorvastatin Calcium market is valued at 160 million US$ in 2018 and will reach 250 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Atorvastatin Calcium market based on company, product type, end user and key regions.

        This report studies the global market size of Atorvastatin Calcium in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Atorvastatin Calcium in these regions.
        This research report categorizes the global Atorvastatin Calcium market by top players/brands, region, type and end user. This report also studies the global Atorvastatin Calcium market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

        The following manufacturers are covered in this report, with sales, revenue, market share for each company:
        Pfizer
        DSM Sinochem Pharmaceuticals
        Cadila Pharmaceuticals
        Sun Pharmaceutical Industries
        Dr. Reddy’s
        Morepen
        Teva Pharmaceutical Industries
        Apotex Pharmachem
        Sandoz Inc
        Mylan Pharmaceuticals Inc.
        Kremers Urban Pharmaceuticals Inc.
        ScieGen Pharmaceuticals, Inc.
        Zheijang Neo-Dankon Pharmaceutical
        Ningbo Menovo Pharmaceuticals Group
        Jialin Pharmaceutical
        Topfond
        Zhejiang Hisun Pharmacutical
        Zhejiang Hongyuan Pharmaceutical
        Hubei Yitai Pharmaceutical
        Jiangsu Hengrui Medicine

        Market size by Product
        Chemical Synthesis
        Biocatalysis
        Others
        Market size by End User
        Tablet (Including Dispersible Tablet and General Tablet)
        Capsule
        Others

        Market size by Region
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Central & South America
        Brazil
        Rest of Central & South America
        Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

        The study objectives of this report are:
        To study and analyze the global Atorvastatin Calcium market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
        To understand the structure of Atorvastatin Calcium market by identifying its various subsegments.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        Focuses on the key global Atorvastatin Calcium companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
        To project the value and sales volume of Atorvastatin Calcium submarkets, with respect to key regions.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

        In this study, the years considered to estimate the market size of Atorvastatin Calcium are as follows:
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025

        This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Atorvastatin Calcium market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.



        Summary:
        Atorvastatin Calcium Market Research Report is Atorvastatin Calcium Market Report. Get Atorvastatin Calcium market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Atorvastatin Calcium . Atorvastatin Calcium Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



        REPORT YOU MIGHT BE INTERESTED